# Universitätsklinikum Hamburg Eppendorf account plan

> UKE is Hamburg's largest hospital and university medical centre, owned by the City of Hamburg, with group revenue of 1,752,999 TEUR in FY2025.

## At a glance

Universitätsklinikum Hamburg-Eppendorf (UKE), founded in 1889, is Hamburg's largest hospital and the maximum-care and last-resort provider for the Hamburg metropolitan region. It is a public-law corporation 100% owned by the Free and Hanseatic City of Hamburg (FHH) and combines patient care with research and teaching as the Medical Faculty of Universität Hamburg. In 2025 the UKE group treated about 595,000 patients across 14 centres with about 80 clinics and institutes, and 13 subsidiaries. FY2025 group revenue was 1,752,999 TEUR with a group annual result of -23,200 TEUR, and the group had 15,678 employees (single entity: 12,291).

## Business units

- **Patient care (Krankenversorgung)** (Hospital operating revenue 888,481 TEUR in FY2024 (+6.9%)): Maximum-care hospital for severe and very rare diseases in the Hamburg region, with 1,715 beds at 84.4% occupancy in 2024. DRG inpatients rose 1.4% to 65,319 and outpatient cases rose by 13,160, helped by a higher Hamburg base rate of EUR 4,211.14.
- **Research and translation (Medical Faculty)** (Research and teaching subsidy EUR 203.4m; third-party funders' allocations EUR 125.8m (FY2024)): Third-party funding income grew 8.3% in 2024, with two new DFG Collaborative Research Centres (EUR 10.8m and EUR 12.0m), 14 Horizon Europe grants and four ERC grants. New research buildings N25 and HCTI/Campus Forschung II are being occupied.
- **Teaching (Lehre)**: Runs the iMED medicine model programme, the iMED DENT dentistry programme and the iMID midwifery bachelor with HAW Hamburg. iMED accreditation was extended to 30 September 2030.
- **Subsidiaries (UKE group)** (13 direct subsidiaries plus four second-tier subsidiaries): Includes AKK Altonaer Kinderkrankenhaus children's hospital (94.0%), the Martini-Klinik prostate cancer centre, the Ambulanzzentrum outpatient centre, service companies for cleaning, catering, logistics and facility management, and IDM gGmbH, UKE's AI subsidiary. Services bought from subsidiaries made up about 46% of UKE's cost increase in 2024.

## Strategic priorities

- **Return to a balanced result**: A medium-term plan agreed with the authorities targets a balanced result again in 2030, after losses of -51,350 TEUR in 2024 and -27,634 TEUR in 2025 (single entity).
- **Zukunftsplan 2050 campus build-out**: The long-term building plan covers the University Heart and Vascular Center, the HCTI/Campus Forschung II research building, N25 and the new Martini-Klinik, financed through a tenant-landlord model (MVM).
- **Digital strategy (Digitale Exzellenz)**: nextKAS replaces the Soarian clinical system with Navis by end-2026, nextERP replaces SAP ERP by end-2027, and nextWIS (research IT and AI) is still unfunded. At end-2024 UKE requested EUR 40.7m from the FHH for these IT needs.
- **Clinical AI built in-house**: Through IDM gGmbH, UKE runs the ambient documentation tool ORPHEUS (in use since early 2025) and the discharge-letter model ARGO, with diagnostics support, individualised therapy and administrative relief as next products.
- **Research growth**: Expand third-party funded research, with new DFG Collaborative Research Centres, Horizon Europe and ERC grants, and the NUM research infrastructures renewed for 2025-2030.

## Latest results

In FY2025, UKE KdöR revenue rose to 1,631,607 TEUR from 1,533,639 TEUR, and the annual result improved to -27,634 TEUR from -51,350 TEUR, but equity stayed at 0. Growth came from higher activity, a higher state base rate, third-party funding and higher city allocations, set against personnel expense of 876,446 TEUR and materials of 530,379 TEUR. At group level, FY2025 revenue was 1,752,999 TEUR (2024: 1,641,774) and the annual result -23,200 TEUR (2024: -46,445), with group equity down to 0. The 2030 balanced-result target is described as much harder to reach, and unreachable if the proposed GKV reform imposes large savings on hospitals.

## Investments and deals

- **Group capital expenditure**: Group fixed-asset investment was 159,585 TEUR in 2025, after 174,511 TEUR in 2024; single-entity fixed-asset investment was 49,644 TEUR in 2025.
- **Fit-out loan for new buildings**: A new EUR 90.0m loan funds the fit-out of the new University Heart and Vascular Center, Martini-Klinik and Campus Forschung II buildings.
- **Clinical IT replacement**: Navis went live at AKK in April 2024, a new radiology PACS in June 2024 and a new cardiology information system in November 2024, with a patient and referrer portal and lab information system due in 2025.
- **Martini-Klinik new building**: Treating patients since mid-2024: 17,000 m² gross floor area, 100 beds on four wards, and more than 2,500 prostate cancer operations a year.

## Challenges and risks

- **Cost inflation not refinanced**: Pay settlements and material costs are not reflected in hospital financing or research and teaching funding; about EUR 12m of nursing refinancing is lost from 2025.
- **Equity used up and tight liquidity**: The 2024 loss left a deficit not covered by equity of 9,433 TEUR and cash fell to EUR 4.5m; liquidity rests on a EUR 92.0m FHH credit line, a EUR 34.9m liquidity loan, EUR 90.0m of bank lines and the group cash pool.
- **Insufficient investment funding**: The tenant-landlord model leaves first equipment of new buildings to UKE's own or loan financing, and cybersecurity, nextERP and research IT cannot be financed from UKE's own resources.
- **Health insurance reform risk**: If the planned GKV reform imposes large savings obligations on hospitals as proposed, the 2030 balanced-result target will no longer be achievable.

## What leadership says

> "Insgesamt wird KI in zehn Jahren ein fester Bestandteil unserer Infrastruktur sein" — Prof. Dr. Christian Gerloff, Medical Director and Chairman of the Executive Board, Techniker Krankenkasse interview "Zur Sache: Künstliche Intelligenz am UKE", 7 September 2026 (within ten years AI will be a fixed part of our infrastructure).

> "Digitale Intelligenz wird menschliche Intelligenz und Nähe nicht ersetzen" — Prof. Dr. Christian Gerloff, Medical Director and Chairman of the Executive Board, Techniker Krankenkasse interview, 7 September 2026 (digital intelligence will not replace human intelligence and closeness).


## Where a supplier can help

- **Clinical system and ERP migration support**: Tied to the Digitale Exzellenz priority: the Soarian-to-Navis replacement by end-2026 and the SAP ERP replacement by end-2027 create demand for migration, integration and interface work.
- **Data integration across clinical systems**: Tied to the clinical AI priority: the CEO names connecting findings, histories and lab results across systems as the next step, so data integration tooling that is proven in real clinical settings fits IDM's stated bar.
- **Equipment for new buildings**: Tied to the Zukunftsplan 2050 and the insufficient investment funding challenge: first equipment for new buildings is not covered by the tenant-landlord model, so financing or leasing models for equipment may be relevant.
- **Cost and efficiency programmes**: Tied to the balanced-result target and cost inflation challenge: offers that reduce material or personnel costs, or administrative workload, address the gap between rising costs and refinancing.
- **Cybersecurity and compliance**: Tied to the investment funding challenge: cybersecurity cannot be financed from UKE's own resources and is largely funded through the Hospital Future Act (KHZG), so offers should fit public funding programmes.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Jahresabschluss and Lagebericht 2024 of Universitätsklinikum Hamburg-Eppendorf KdöR (Amtlicher Anzeiger Nr. 98)](https://www.luewu.de/wp-content/uploads/2025/12/AANZ_HH_2025-98.pdf)

Annual report · 2025-12-19

- Universitätsklinikum Hamburg-Eppendorf (UKE), founded in 1889, is Hamburg's largest hospital and its maximum-care and last-resort provider. It is a public-law corporation 100% owned by the City of Hamburg (FHH) and combines the hospital with the Medical Faculty of Universität Hamburg. It has 13 direct subsidiaries, including the Altonaer Kinderkrankenhaus children's hospital (94.0%) and the Martini-Klinik prostate cancer centre.
- FY2024 (UKE KdöR, audited, published 19 December 2025): hospital operating revenue 888,481 TEUR (+6.9%), public grants and subsidies 378,352 TEUR (+12.8%), and an **annual loss of 51,350 TEUR** (2023: profit of 804 TEUR), better than the planned deficit of 60,398 TEUR.
- The loss used up equity for the first time, leaving a deficit not covered by equity of 9,433 TEUR. Cash fell to EUR 4.5m. Liquidity rests on a EUR 92.0m FHH credit line, a EUR 34.9m liquidity loan, EUR 90.0m of bank lines and the group cash pool. A new EUR 90.0m loan funds the fit-out of the new buildings.
- Activity: 1,715 beds at 84.4% occupancy, DRG inpatients +1.4% to 65,319, case mix index 1.425, and outpatient cases up by 13,160. The Hamburg base rate rose to EUR 4,211.14.
- Costs: personnel 817,722 TEUR (+6.3%) and materials 503,051 TEUR (+4.2%). FTE rose by 537 to 8,741 at year-end, mostly in nursing, and the average headcount was 11,544 employees.
- Strategy: the Zukunftsplan 2050 campus build-out (Heart and Vascular Center, Martini-Klinik, HCTI/Campus Forschung II) and the digital-excellence IT strategy (Digitale Exzellenz). nextKAS replaces the Soarian clinical system with Navis by end-2026, nextERP replaces SAP ERP by end-2027, and nextWIS (research IT and AI) is unfunded. UKE asked the FHH for EUR 40.7m for IT.
- Research: two new DFG Collaborative Research Centres (EUR 10.8m and EUR 12.0m), 14 Horizon Europe grants and four ERC grants.
- Risks: pay and material inflation are not refinanced by hospital or research funding, about EUR 12m of nursing refinancing is lost from 2025, investment funding is insufficient, and new buildings come without first equipment under the tenant-landlord model.
- Outlook: the 2025 plan was rejected by the supervisory board in December 2024 and resubmitted in May 2025, and the 2025 deficit will again be significant. Board: Prof. Dr. Christian Gerloff (Chair), Corinna Wriedt (Commercial Director since 1 July 2024), Joachim Prölß and Prof. Dr. Blanche Schwappach-Pignataro.

### [Beteiligungsbericht 2025 extract: Universitätsklinikum Hamburg-Eppendorf KdöR (FY2025 key figures)](https://dokumente.hamburg.de/resource/blob/1109600/e19991a3695f3d0b05c6195dcd3dd2bd/uke-bildung-und-wissenschaft-data.pdf)

Report

- The City of Hamburg's investment report entry on UKE KdöR is the latest source of UKE's FY2025 audited figures.
- FY2025 revenue was 1,631,607 TEUR (2024: 1,533,639) and the **annual result was -27,634 TEUR**, improving from -51,350 TEUR in 2024 but still a loss. Equity stays at 0.
- Personnel expense was 876,446 TEUR and materials 530,379 TEUR. Growth came from higher activity, a higher state base rate, third-party funding and higher city allocations (MVM and *Verschränkungskosten*, raised by Drucksache 23/1662).
- Scale: in 2025 the UKE group treated about 595,000 patients (98,000 inpatient, 497,000 outpatient, about 128,000 via the emergency department). It runs 14 centres with about 80 clinics and institutes, and 13 subsidiaries.
- Employees rose to 12,291 (11,544), with 1,049 trainees. Average gross income of permanent staff was EUR 73,000.
- Outlook: the medium-term plan targets a balanced result in 2030. That is now much harder, and unreachable if the proposed GKV reform imposes large savings on hospitals.
- Governance: Senator Maryam Blumenthal has chaired the Kuratorium since 04.06.2025. CEO Prof. Dr. Christian Gerloff's 2025 pay was EUR 673,258. The auditor is Forvis Mazars.
- Fixed-asset investment was 49,644 TEUR. Scope 1+2 emissions were 24,320 t CO2e.

### [Beteiligungsbericht 2025 extract: UKE group (Konzern) consolidated key figures FY2025](https://dokumente.hamburg.de/resource/blob/1109588/0c058b9d5d778ab42c127d0499bb151e/konzern-uke-bildung-und-wissenschaft-data.pdf)

Report

- The City of Hamburg's investment report entry on the UKE group (consolidated, figures 2023-2025): UKE KdöR plus 13 subsidiaries and 4 second-tier subsidiaries, with the consolidation scope unchanged.
- FY2025 group revenue was 1,752,999 TEUR (2024: 1,641,774; 2023: 1,548,191).
- **Group annual result: -23,200 TEUR** in 2025, after -46,445 in 2024 and +2,038 in 2023.
- Personnel expense was 1,066,892 TEUR and materials 466,104 TEUR. Other operating expenses rose to 334,548 TEUR.
- Group equity fell to 0 (13,282 in 2024). Liabilities were 1,032,843 TEUR and total assets 1,917,761 TEUR.
- Group capex was 159,585 TEUR in 2025 (174,511 in 2024).
- Group employees rose to 15,678 (14,872), mainly in nursing and the service companies.
- Group Scope 1+2 emissions were 25,819 t CO2e, with energy use of 162,198 MWh.

### [Zur Sache: Künstliche Intelligenz am UKE (TK interview with Christian Gerloff and Nils Schweingruber)](https://www.tk.de/presse/themen/digitale-gesundheit/kuenstliche-intelligenz/ki-am-uke-2179856)

Executive talk · Prof. Dr. Christian Gerloff, Medical Director and Chairman of the Executive Board · 2026-09-07

- Interview of Prof. Dr. Christian Gerloff (Medical Director and CEO of UKE) and Dr. Nils Schweingruber (managing director of UKE's AI subsidiary IDM gGmbH) by Techniker Krankenkasse, 7 September 2026.
- Gerloff: UKE introduced a hospital-wide electronic patient record in 2009, the first university hospital in Europe to do so. The next step is to connect findings, histories and lab results across systems with AI.
- Gerloff expects AI to be a fixed part of UKE's infrastructure within ten years, from documentation to flagging connections for clinicians, but "Digitale Intelligenz wird menschliche Intelligenz und Nähe nicht ersetzen" (translation: digital intelligence will not replace human intelligence and closeness).
- ORPHEUS, an ambient AI documentation tool, has been used at UKE since early 2025 and has since been adopted by many other hospitals. It produces structured notes with coding suggestions from the doctor-patient conversation.
- ARGO, IDM's discharge-letter language model, now also merges findings, histories and lab results for the care team. Next products target diagnostics support, individualised therapy and administrative relief.
- UKE develops clinical AI in-house on campus through IDM, and IDM insists systems must be developed and tested in real clinical situations.

## Questions about Universitätsklinikum Hamburg Eppendorf

### What does UKE do?

UKE is Hamburg's largest hospital and the maximum-care and last-resort provider for the Hamburg region. It also carries out research and teaching as the Medical Faculty of Universität Hamburg, and in 2025 the group treated about 595,000 patients.

### What is UKE's revenue?

UKE group revenue was 1,752,999 TEUR in FY2025, with a group annual result of -23,200 TEUR. The single entity UKE KdöR had revenue of 1,631,607 TEUR and a result of -27,634 TEUR.

### How many people work at UKE?

The UKE group had 15,678 employees in 2025; the single entity UKE KdöR had 12,291 employees, including 1,049 trainees.

### Who owns and leads UKE?

UKE is 100% owned by the City of Hamburg. Prof. Dr. Christian Gerloff chairs the Executive Board as Medical Director, with Corinna Wriedt as Commercial Director, Joachim Prölß and Prof. Dr. Blanche Schwappach-Pignataro.

### What is UKE's strategy?

UKE is building out its campus under the Zukunftsplan 2050, replacing its clinical and ERP systems under the Digitale Exzellenz strategy, developing clinical AI through IDM gGmbH, and aims for a balanced result in 2030.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
